On March 30, Co-Chair of Willkie’s Capital Markets practice Eddie Best appeared on Dealcast, Mergermarket’s M&A podcast, to discuss the SEC’s regulatory shift over the past year and its impact on capital markets. He discussed the agency’s moves to simplify IPO processes and eliminate...

Willkie advised Mueller Industries, Inc. (NYSE: MLI) on its acquisition of Bison Metals Technologies LLC, a U.S. manufacturer of copper tubes.   Mueller Industries, Inc. is an industrial corporation whose holdings manufacture vital goods for important markets such as air, water, oil and...

Willkie advised the arranger and the permanent dealers on a €13 billion Treasury Notes Programme for the Brussels Capital Region.   The Brussels Capital Region (la Région de Bruxelles-Capitale/het BrusselsHoofdstedelijk Gewest) is a federated entity of the Kingdom of Belgium.   The Willkie...

On April 13 at 10:45 am (ET), partners Daniel Alvarez and Kara Baysinger will participate as speakers on the panel titled “Steering Through Cyber Fishtails and Lock-ups: Responding to Cyber Threats at Full Speed.” The panel is part of the 2026 National School on Market Regulation, hosted...

Willkie partner Gavin Gordon, Chair of the European Private Equity Practice Group and a member of the Firm's Executive Committee, was profiled by Law360 as part of its UK Expert Analysis series. The in-depth article addressed emerging issues in the private equity industry, the keys to...

Willkie represented XGS Energy, a developer of next-generation geothermal power systems, in its partnership with Baker Hughes, an energy technology company, to develop a 150-megawatt geothermal project in New Mexico. XGS and Baker Hughes recently announced a strategic collaboration and...

Willkie advised Insight Partners as lead investor in a $130 million Series C funding round for ScaleOps, a leading platform for autonomous cloud and AI infrastructure resource management. On March 30, ScaleOps announced that it raised $130 million in Series C funding at a valuation exceeding...

Willkie is representing Stifel, Nicolaus & Company, Incorporated, as sales agent, in connection with the SEC-registered at-the-market equity offering by Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer cell therapies to treat autoimmune...